Royalty Pharma Class A Shs financial statements
로열티 파머NASDAQ:RPRX · Nasdaq · Healthcare$56.66-0.87%
2026-10-05 closeRoyalty Pharma Class A Shs's published financial data is dated 2026-10-04. 2024 revenue was $2.26B. 2024 operating profit was $1.29B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy